At Princess Margaret, we recommend active surveillance for all patients with clinical stage I nonseminomatous germ cell tumor. Here we refute common arguments against surveillance and urge clinicians to engage in a shared decision-making process that goes beyond merely citing relapse rates for the different options.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.euf.2019.05.003 | DOI Listing |
Publication Analysis
Top Keywords
stage nonseminomatous
8
nonseminomatous germ
8
germ cell
8
cell tumor
8
optimal management
4
management high-risk
4
high-risk stage
4
tumor surveillance
4
surveillance preferred
4
preferred option
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!